adverse drug reactions (ADRs), side effects of drugs, medication adherence (MARS), beliefs about medicines necessity and concerns (BMQ), self efficacy (MUSE)
Conditions
Interventions
All participating pharmacists receive material and written instructions for patient selection, interventions and process registrations. Pharmacists are supported by the researcher in following the stu
their medication review starts subsequent to this measurement.
Sponsors
Radboud university medical center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen, The Netherlands
Eligibility
Inclusion criteria
Inclusion criteria: Patients eligible for a community pharmacist-led medication review according to the guidelines (use of 5 or more prescribed chronic systemic drugs). Other criteria to achieve the intended study population of 20 patients per pharmacy to be determined by the pharmacist, like: age over 65, specific chronic diseases, general practitioner (GP) of the patient.
Exclusion criteria
Exclusion criteria: To be assessed by the community pharmacists considering: - cognitive or communication impairments; - other recently performed pharmacotherapy interventions; - not willing or unable to participate in study according to GP.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total number of ADRs, as reported through the PROM questionnaire at follow up measurement. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient reported scores on health perception, beliefs about medication (BMQ) necessity, beliefs about medication (BMQ) concerns, self efficacy (MUSE), and medication adherence (MARS) at follow up measurement. Change of the number of patients who report ADRs at follow up measurement. Change of the ADRs that were reported at baseline at follow up measurement compared between the intervention and the control group. | — |
Contacts
Public ContactT. Schoenmakers
Pharmacist, PhD Student Radboud University Medical Center P.O. Box 9101, 6500 HB Nijmegen
Outcome results
None listed